Mylan Inc (MYL.OQ)
10 Mar 2014
|Market Cap (Mil.):||$19,863.85|
|Shares Outstanding (Mil.):||371.91|
(Corrects ninth paragraph to show Forest Labs, not Mylan, as best performer on the S&P 500)
Feb 18 - Generic drugmaker Actavis Plc said it would acquire specialty pharmaceuticals company Forest Laboratories Inc in a cash and stock deal valued at about $25 billion.
ZURICH - Pharmaceutical group Roche said it secured an injunction from an Indian court banning generic drug makers Biocon and Mylan from comparing their copycat versions of Roche's Herceptin breast cancer treatment to the original.
ZURICH, Feb 7 - Pharmaceutical group Roche said it secured an injunction from an Indian court banning generic drug makers Biocon and Mylan from comparing their copycat versions of Roche's Herceptin breast cancer treatment to the original.
NEW YORK - Drugmakers Valeant Pharmaceuticals International Inc , Actavis Plc and Mylan Inc have all expressed interest in buying Pfizer Inc's branded generics business, but no active discussions are going on at this time, according to three people close to the matter.
NEW DELHI, Nov 26 - Biocon Ltd said on Tuesday it has won the Indian drug regulator's approval for marketing a generic version of Roche's Herceptin breast cancer treatment.
Note: Reuters has not verified this story and does not vouch for its accuracy.
Nov 18 - Mylan Inc : * Launches first generic Focalin XR capsules, 30 mg * Says awarded 180 days marketing exclusivity * Says dexmethylphenidate hydrochloride extended-release capsules, 30 mg, is the first generic version of novartis' focalin xr * Source text for Eikon * Further company coverage
* Says took remedial action on US FDA warning on Agila unit plant
Sept 27 - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:
|Dr. Reddy's Laboratories Limited (REDY.NS)||Rs2,678.70||-7.95|
|Johnson & Johnson (JNJ.N)||$93.45||+0.13|
|Pfizer Inc. (PFE.N)||$32.39||-0.04|
|Novartis AG (NOVN.VX)||CHF72.85||+0.25|
|Merck & Co., Inc. (MRK.N)||$57.32||-0.15|
|Roche Holding Ltd. (ROG.VX)||CHF261.30||+0.80|
|Abbott Laboratories (ABT.N)||$39.82||+0.25|
|Bayer AG (BAYGn.DE)||€96.14||-0.30|
|Bayer AG (BAYE.F)||--||--|
|GlaxoSmithKline plc (GSK.L)||1,669.00p||-3.50|
Earnings vs. Estimates
Analyst Research Reports
Trading Report for (MYL). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
Provider: Wright Reports
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: S&P Capital IQ – STARS Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.